KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to -$48.9 million.

  • Biogen's Consolidated Net Income fell 11833.52% to -$48.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 billion, marking a year-over-year decrease of 2078.79%. This contributed to the annual value of $1.3 billion for FY2025, which is 2078.79% down from last year.
  • As of Q4 2025, Biogen's Consolidated Net Income stood at -$48.9 million, which was down 11833.52% from $466.5 million recorded in Q3 2025.
  • In the past 5 years, Biogen's Consolidated Net Income ranged from a high of $1.1 billion in Q3 2022 and a low of -$68.3 million during Q3 2023
  • For the 5-year period, Biogen's Consolidated Net Income averaged around $436.9 million, with its median value being $391.0 million (2024).
  • In the last 5 years, Biogen's Consolidated Net Income soared by 153848.17% in 2022 and then tumbled by 11833.52% in 2025.
  • Over the past 5 years, Biogen's Consolidated Net Income (Quarter) stood at -$38.2 million in 2021, then skyrocketed by 1538.48% to $549.5 million in 2022, then crashed by 54.7% to $248.9 million in 2023, then grew by 7.15% to $266.7 million in 2024, then tumbled by 118.34% to -$48.9 million in 2025.
  • Its Consolidated Net Income stands at -$48.9 million for Q4 2025, versus $466.5 million for Q3 2025 and $634.8 million for Q2 2025.